BRIEF-Sino Biopharmaceutical Says Unit Entered Into Joint Venture Contract With Akeso Biopharma

June 17 (Reuters) - Sino Biopharmaceutical Ltd:

* CHIA-TAI TIANQING PHARMACEUTICAL ENTERED INTO JOINT VENTURE CONTRACT WITH AKESO BIOPHARMA, INC. TO ESTABLISH JV CO

* REGISTERED CAPITAL OF JV SHALL BE IN RMB689.45 MILLION, OF WHICH RMB344.725 MILLION WILL BE CONTRIBUTED BY CHIA-TAI TIANQING IN CASH

* JV FOR PURPOSE TO JOINTLY DEVELOP PROJECT OF RECOMBINANT HUMANIZED ANTI PD-1 MONOCLONAL ANTIBODY AK105 DRUG Source text for Eikon: Further company coverage:

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting